Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale

ABSTRACT Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current medical research and opinion 2005-05, Vol.21 (5), p.749-760
Hauptverfasser: Cappelleri, Joseph C., Bushmakin, Andrew G., Baker, Christine L., Merikle, Elizabeth, Olufade, Abayomi O., Gilbert, David G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 760
container_issue 5
container_start_page 749
container_title Current medical research and opinion
container_volume 21
creator Cappelleri, Joseph C.
Bushmakin, Andrew G.
Baker, Christine L.
Merikle, Elizabeth
Olufade, Abayomi O.
Gilbert, David G.
description ABSTRACT Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS. Research design and methods: Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study ( n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies ( n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses. Main outcome measures: The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep. Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme). Results: Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains – Negative Affect with four items and Insomnia with two items – and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70. Conclusions: Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS.
doi_str_mv 10.1185/030079905X43712
format Article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1185_030079905X43712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>851726571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-7612003c675403a3af125b53ac8aa548863f5b0b1e6492a532231a4e5259f27d3</originalsourceid><addsrcrecordid>eNp1kEtLAzEUhYMoWqtrdzK4H5vnZOJOii9QBB_gbridydjoTFKT1OK_N7WFouDqLs53DpcPoSOCTwkpxQgzjKVSWLxwJgndQgPCJct5KeU2GizTPMViD-2H8IYxoaVSu2iPCFWoUvIBenzQnxo6Y1-zONVZP--iaUyvbTDOQpe1Hnq9cP49c-0PcWes1cFFyKypXTRWZwsTp42HRcJDDZ0-QDstdEEfru8QPV9ePI2v89v7q5vx-W1ec8piLgtCMWZ1IQXHDBi0hIqJYFCXAIKXZcFaMcEToguuKAhGKSPAtaBCtVQ2bIhOVrsz7z7mOsTqzc19-jpUNFkpOBcyQaMVVHsXgtdtNfOmB_9VEVwtHVZ_HKbG8Xp2Pul1s-HX0hJwtgKMbZ3vIenpmirCV-d88mVrEyr2_7r6VZ4m-3Fag9eb7__rfgOYL5Bz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>207964457</pqid></control><display><type>article</type><title>Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale</title><source>MEDLINE</source><source>Taylor &amp; Francis:Master (3349 titles)</source><source>Taylor &amp; Francis Medical Library - CRKN</source><creator>Cappelleri, Joseph C. ; Bushmakin, Andrew G. ; Baker, Christine L. ; Merikle, Elizabeth ; Olufade, Abayomi O. ; Gilbert, David G.</creator><creatorcontrib>Cappelleri, Joseph C. ; Bushmakin, Andrew G. ; Baker, Christine L. ; Merikle, Elizabeth ; Olufade, Abayomi O. ; Gilbert, David G.</creatorcontrib><description>ABSTRACT Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS. Research design and methods: Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study ( n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies ( n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses. Main outcome measures: The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep. Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme). Results: Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains – Negative Affect with four items and Insomnia with two items – and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70. Conclusions: Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS.</description><identifier>ISSN: 0300-7995</identifier><identifier>EISSN: 1473-4877</identifier><identifier>DOI: 10.1185/030079905X43712</identifier><identifier>PMID: 15969874</identifier><identifier>CODEN: CMROCX</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Benzazepines - therapeutic use ; Craving ; Factor analysis ; Factor Analysis, Statistical ; Female ; Humans ; Male ; Middle Aged ; Minnesota ; Nicotine ; Nicotinic Agonists - therapeutic use ; Psychometrics ; Psychometrics - instrumentation ; Quinoxalines - therapeutic use ; Reliability ; Reproducibility of Results ; Severity of Illness Index ; Sickness Impact Profile ; Smoking cessation ; Smoking Cessation - psychology ; Substance Withdrawal Syndrome - physiopathology ; Substance Withdrawal Syndrome - psychology ; Surveys and Questionnaires ; Tobacco Use Disorder - drug therapy ; Validity ; Varenicline ; Withdrawal scale</subject><ispartof>Current medical research and opinion, 2005-05, Vol.21 (5), p.749-760</ispartof><rights>2005 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2005</rights><rights>Copyright Librapharm May 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-7612003c675403a3af125b53ac8aa548863f5b0b1e6492a532231a4e5259f27d3</citedby><cites>FETCH-LOGICAL-c423t-7612003c675403a3af125b53ac8aa548863f5b0b1e6492a532231a4e5259f27d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1185/030079905X43712$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1185/030079905X43712$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,59646,59752,60435,60541,61220,61255,61401,61436</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15969874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cappelleri, Joseph C.</creatorcontrib><creatorcontrib>Bushmakin, Andrew G.</creatorcontrib><creatorcontrib>Baker, Christine L.</creatorcontrib><creatorcontrib>Merikle, Elizabeth</creatorcontrib><creatorcontrib>Olufade, Abayomi O.</creatorcontrib><creatorcontrib>Gilbert, David G.</creatorcontrib><title>Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale</title><title>Current medical research and opinion</title><addtitle>Curr Med Res Opin</addtitle><description>ABSTRACT Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS. Research design and methods: Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study ( n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies ( n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses. Main outcome measures: The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep. Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme). Results: Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains – Negative Affect with four items and Insomnia with two items – and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70. Conclusions: Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Benzazepines - therapeutic use</subject><subject>Craving</subject><subject>Factor analysis</subject><subject>Factor Analysis, Statistical</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Minnesota</subject><subject>Nicotine</subject><subject>Nicotinic Agonists - therapeutic use</subject><subject>Psychometrics</subject><subject>Psychometrics - instrumentation</subject><subject>Quinoxalines - therapeutic use</subject><subject>Reliability</subject><subject>Reproducibility of Results</subject><subject>Severity of Illness Index</subject><subject>Sickness Impact Profile</subject><subject>Smoking cessation</subject><subject>Smoking Cessation - psychology</subject><subject>Substance Withdrawal Syndrome - physiopathology</subject><subject>Substance Withdrawal Syndrome - psychology</subject><subject>Surveys and Questionnaires</subject><subject>Tobacco Use Disorder - drug therapy</subject><subject>Validity</subject><subject>Varenicline</subject><subject>Withdrawal scale</subject><issn>0300-7995</issn><issn>1473-4877</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kEtLAzEUhYMoWqtrdzK4H5vnZOJOii9QBB_gbridydjoTFKT1OK_N7WFouDqLs53DpcPoSOCTwkpxQgzjKVSWLxwJgndQgPCJct5KeU2GizTPMViD-2H8IYxoaVSu2iPCFWoUvIBenzQnxo6Y1-zONVZP--iaUyvbTDOQpe1Hnq9cP49c-0PcWes1cFFyKypXTRWZwsTp42HRcJDDZ0-QDstdEEfru8QPV9ePI2v89v7q5vx-W1ec8piLgtCMWZ1IQXHDBi0hIqJYFCXAIKXZcFaMcEToguuKAhGKSPAtaBCtVQ2bIhOVrsz7z7mOsTqzc19-jpUNFkpOBcyQaMVVHsXgtdtNfOmB_9VEVwtHVZ_HKbG8Xp2Pul1s-HX0hJwtgKMbZ3vIenpmirCV-d88mVrEyr2_7r6VZ4m-3Fag9eb7__rfgOYL5Bz</recordid><startdate>200505</startdate><enddate>200505</enddate><creator>Cappelleri, Joseph C.</creator><creator>Bushmakin, Andrew G.</creator><creator>Baker, Christine L.</creator><creator>Merikle, Elizabeth</creator><creator>Olufade, Abayomi O.</creator><creator>Gilbert, David G.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Informa Healthcare</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>200505</creationdate><title>Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale</title><author>Cappelleri, Joseph C. ; Bushmakin, Andrew G. ; Baker, Christine L. ; Merikle, Elizabeth ; Olufade, Abayomi O. ; Gilbert, David G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-7612003c675403a3af125b53ac8aa548863f5b0b1e6492a532231a4e5259f27d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Benzazepines - therapeutic use</topic><topic>Craving</topic><topic>Factor analysis</topic><topic>Factor Analysis, Statistical</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Minnesota</topic><topic>Nicotine</topic><topic>Nicotinic Agonists - therapeutic use</topic><topic>Psychometrics</topic><topic>Psychometrics - instrumentation</topic><topic>Quinoxalines - therapeutic use</topic><topic>Reliability</topic><topic>Reproducibility of Results</topic><topic>Severity of Illness Index</topic><topic>Sickness Impact Profile</topic><topic>Smoking cessation</topic><topic>Smoking Cessation - psychology</topic><topic>Substance Withdrawal Syndrome - physiopathology</topic><topic>Substance Withdrawal Syndrome - psychology</topic><topic>Surveys and Questionnaires</topic><topic>Tobacco Use Disorder - drug therapy</topic><topic>Validity</topic><topic>Varenicline</topic><topic>Withdrawal scale</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cappelleri, Joseph C.</creatorcontrib><creatorcontrib>Bushmakin, Andrew G.</creatorcontrib><creatorcontrib>Baker, Christine L.</creatorcontrib><creatorcontrib>Merikle, Elizabeth</creatorcontrib><creatorcontrib>Olufade, Abayomi O.</creatorcontrib><creatorcontrib>Gilbert, David G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Current medical research and opinion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cappelleri, Joseph C.</au><au>Bushmakin, Andrew G.</au><au>Baker, Christine L.</au><au>Merikle, Elizabeth</au><au>Olufade, Abayomi O.</au><au>Gilbert, David G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale</atitle><jtitle>Current medical research and opinion</jtitle><addtitle>Curr Med Res Opin</addtitle><date>2005-05</date><risdate>2005</risdate><volume>21</volume><issue>5</issue><spage>749</spage><epage>760</epage><pages>749-760</pages><issn>0300-7995</issn><eissn>1473-4877</eissn><coden>CMROCX</coden><abstract>ABSTRACT Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS. Research design and methods: Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study ( n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies ( n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses. Main outcome measures: The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep. Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme). Results: Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains – Negative Affect with four items and Insomnia with two items – and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70. Conclusions: Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>15969874</pmid><doi>10.1185/030079905X43712</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-7995
ispartof Current medical research and opinion, 2005-05, Vol.21 (5), p.749-760
issn 0300-7995
1473-4877
language eng
recordid cdi_informahealthcare_journals_10_1185_030079905X43712
source MEDLINE; Taylor & Francis:Master (3349 titles); Taylor & Francis Medical Library - CRKN
subjects Adolescent
Adult
Aged
Benzazepines - therapeutic use
Craving
Factor analysis
Factor Analysis, Statistical
Female
Humans
Male
Middle Aged
Minnesota
Nicotine
Nicotinic Agonists - therapeutic use
Psychometrics
Psychometrics - instrumentation
Quinoxalines - therapeutic use
Reliability
Reproducibility of Results
Severity of Illness Index
Sickness Impact Profile
Smoking cessation
Smoking Cessation - psychology
Substance Withdrawal Syndrome - physiopathology
Substance Withdrawal Syndrome - psychology
Surveys and Questionnaires
Tobacco Use Disorder - drug therapy
Validity
Varenicline
Withdrawal scale
title Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A33%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Revealing%20the%20multidimensional%20framework%20of%20the%20Minnesota%20nicotine%20withdrawal%20scale&rft.jtitle=Current%20medical%20research%20and%20opinion&rft.au=Cappelleri,%20Joseph%20C.&rft.date=2005-05&rft.volume=21&rft.issue=5&rft.spage=749&rft.epage=760&rft.pages=749-760&rft.issn=0300-7995&rft.eissn=1473-4877&rft.coden=CMROCX&rft_id=info:doi/10.1185/030079905X43712&rft_dat=%3Cproquest_infor%3E851726571%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=207964457&rft_id=info:pmid/15969874&rfr_iscdi=true